Objectives: Group A Streptococcus (GAS) is the most common bacterial cause of pediatric acute pharyngitis, and its quick identification is important for subsequent treatment. We sought to determine whether molecular GAS-based testing can successfully replace GAS antigen testing and subsequent culture in a pediatric urgent care center. Methods: We tested 160 patient oropharyngeal samples by a rapid antigen GAS test, the Alere i Strep A test, and throat culture in a pediatric urgent care setting and calculated basic statistical metrics. Results: The sensitivity and specificity of the molecular test were 98% and 100%, respectively, compared with culture. There was a 9% false-positive rate with the rapid antigen-based testing. Conclusions: The Alere test is sufficiently sensitive and specific for definitive GAS testing in a pediatric urgent care setting. This implementation has enabled us to provide definitive patient results at the time of each patient encounter.
Objectives:Group A Streptococcus (GAS) is the most common bacterial cause of pediatric acute pharyngitis, and its quick identification is important for subsequent treatment. We sought to determine whether molecular GAS-based testing can successfully replace GAS antigen testing and subsequent culture in a pediatric urgent care center. Methods: We tested 160 patient oropharyngeal samples by a rapid antigen GAS test, the Alere i Strep A test, and throat culture in a pediatric urgent care setting and calculated basic statistical metrics. Results: The sensitivity and specificity of the molecular test were 98% and 100%, respectively, compared with culture. There was a 9% false-positive rate with the rapid antigen-based testing. Conclusions: The Alere test is sufficiently sensitive and specific for definitive GAS testing in a pediatric urgent care setting. This implementation has enabled us to provide definitive patient results at the time of each patient encounter.
Authors: Hannah Fraser; Daniel Gallacher; Felix Achana; Rachel Court; Sian Taylor-Phillips; Chidozie Nduka; Chris Stinton; Rebecca Willans; Paramjit Gill; Hema Mistry Journal: Health Technol Assess Date: 2020-06 Impact factor: 4.014
Authors: N Kanwar; J Crawford; C Ulen; T S Uphoff; J Dien Bard; R Dunn; A Drain; R Selvarangan Journal: J Clin Microbiol Date: 2019-01-30 Impact factor: 5.948
Authors: Anna P Ralph; Deborah C Holt; Sharifun Islam; Joshua Osowicki; David E Carroll; Steven Y C Tong; Asha C Bowen Journal: Open Forum Infect Dis Date: 2019-02-26 Impact factor: 3.835
Authors: Jeffrey M Pernica; Fiona Smaill; April J Kam; Amy Bartholomew; Quynh Doan; Marek Smieja; Sarah Khan; Melani Sung; Lehana Thabane; David M Goldfarb Journal: BMJ Open Date: 2021-08-11 Impact factor: 2.692